iVexSol
Where technology meets capacity
Lexington, United States
11 employees
Series A
Total: $39.05M
Manufacturing
General Information
Lexington, United States
BounceWatch is an independent company data service, not affiliated with iVexSol. To contact iVexSol, visit ivexsol.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does iVexSol compare?
A PDF of iVexSol and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting iVexSol soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Manufacturing
About iVexSol
Business keywords: Lentiviral vectors, Gene therapy, Vector production, Cell and gene therapies, Medical technology, Supply chain solutions, Life-altering therapies, Biopharmaceutical manufacturing, Clinical development, Global access, Healthcare innovation
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $23.80M | 5 |
|
26 Jan 2023 |
| Series A | $13.00M | 2 |
|
01 Dec 2020 |
| Convertible Note | $250.00K | 1 |
Massachusetts Life Sciences Center
|
25 Aug 2020 |
| Debt Financing | $2.00M | 2 |
|
26 Sep 2019 |
iVexSol Alternatives & Competitors
View All Alternatives
Your Advanced Cell & Gene Therapy CDMO Partner
Accelerate Biotechnology
We work side by side with our customers to improve patients’ lives by bringing new biopharmaceutical...
FAQ About iVexSol
Source: BounceWatch company record for iVexSol, https://bouncewatch.com/company/ivexsol, updated 6 January 2025. When citing, please name BounceWatch and link this page.
